Media Center

Filter by year:

Nov 01, 2023

Generate:Biomedicines and Roswell Park Comprehensive Cancer Center Enter into a Collaboration Agreement to Accelerate Novel Cell Therapies for Oncology Using Generative AI

Sep 14, 2023

Generate:Biomedicines Announces Close of $273M Series C Financing to Advance Its Generative AI Pipeline of Preclinical and Clinical Protein Therapeutics

Jun 26, 2023

Generate:Biomedicines Unveils State-of-the-Art CryoEM Laboratory to Accelerate Generative AI Drug Discovery and Development

Jun 12, 2023

Generate:Biomedicines Appoints Dr. Alexandra Snyder as Executive Vice President, Research & Development

Apr 27, 2023

Generate:Biomedicines and MD Anderson Enter Co-Development and Commercialization Agreement to Accelerate Novel Protein Therapeutics for Oncology Using Generative AI

Mar 22, 2023

Generate:Biomedicines Names Beth Grous Chief People Officer

Jan 05, 2023

Generate:Biomedicines to Present at the 41st Annual J.P. Morgan Healthcare Conference

Dec 07, 2022

Generate:Biomedicines Demonstrates a Novel Method of Reducing Immunogenicity through Protein Re-surfacing

Dec 07, 2022

Generate:Biomedicines Expands Board of Directors with Jane Mendillo, Former CEO of The Harvard Management Company

'